封面
市场调查报告书
商品编码
1877842

2025年人工智慧(AI)控制灌註生物反应器市场报告

Perfusion Bioreactor With Artificial Intelligence (AI) Control Global Market Report 2025

出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来,人工智慧(AI)控制的灌註生物反应器市场规模迅速扩张,预计将从2024年的15.5亿美元成长到2025年的18.8亿美元,复合年增长率(CAGR)为21.3%。过去几年的成长可归因于一次性生物反应器的日益普及、生物製药研发投入的增加、对高效细胞培养系统需求的增长、对连续生物加工方法的日益重视以及生产过程自动化程度的提高。

预计未来几年,人工智慧(AI)控制的灌註生物反应器市场将呈指数级增长,到2029年市场规模将达到40.2亿美元,复合年增长率(CAGR)为20.9%。预测期内的成长要素包括:数位健康技术的日益普及、对混合生物反应器解决方案的偏好不断增强、对先进监测系统的需求不断增长、个性化医疗应用的不断拓展以及政府对生物製程创新的日益支持。预测期内的主要趋势包括:人工智慧驱动控制平台的技术进步、连续生物製程方法的创新、自动化监测和控制系统的开发、精准医疗应用的研究与开发以及与数位化製造生态系统的融合。

未来几年,人工智慧(AI)控制的灌註生物反应器市场预计将受到个人化医疗日益普及的推动。个人化医疗是一种根据个人的基因、分子和临床特征调整治疗方法的医疗方法,旨在实现更精准有效的治疗。基因组学技术的进步使得基于患者基因谱的治疗方法成为可能,从而提高了疗效和安全性,进而推动了对个人化医疗的需求。人工智慧(AI)控制的灌註生物反应器透过在严格控制的条件下精确、连续地生产患者特异性细胞(例如干细胞和工程组织)来支持个人化医疗。例如,根据美国非营利组织个人化医疗联盟(Personalized Medicine Coalition)称,截至2024年2月,美国食品药物管理局(FDA)在2023年核准了16种用于治疗罕见疾病患者的新型个人化疗法,高于2022年的6种。这些新核准的疗法包括7种癌症药物和3种其他疾病的治疗方法。因此,个人化医疗的日益普及推动了人工智慧(AI)控制灌註生物反应器市场的成长。

人工智慧(AI)控制灌註生物反应器市场的主要企业正致力于开发创新解决方案,例如AI增强型即时生物过程监测,以优化细胞培养性能、提高产品产量并降低生物製药生产的营运成本。 AI增强型即时生物製程监测利用人工智慧演算法持续分析生物反应器数据,并提供即时洞察、预测性调整以及生物製造过程中细胞生长和产品品质的最佳化。例如,2025年2月,总部位于德国的生物技术公司The Cultivated B GmbH推出了AI驱动的多通道生物感测器,以增强对用于细胞培养和发酵过程的生物反应器的即时监测。这些生物感测器提供连续、高解析度的数据分析,使生物製程工程师能够以亚皮摩尔级的灵敏度检测葡萄糖、胺基酸和乳酸等分子,从而追踪细胞生长和代谢过程。人工智慧的整合可提供即时洞察和建议,以优化培养基成分,提高测量精度,消除人工取样以最大限度地降低污染风险,并加速製药、生技药品、食品生物技术、废弃物增值回收和替代蛋白质生产领域的产品开发。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场:宏观经济情景,包括利率、通货膨胀、地缘政治、贸易战和关税,以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球人工智慧(AI)控制灌註生物反应器市场:PESTEL 分析(政治、社会、技术、环境、法律因素、驱动因素和限制因素)
  • 终端用户产业分析
  • 全球人工智慧(AI)控制灌註生物反应器市场:成长率分析
  • 全球人工智慧(AI)控制灌註生物反应器市场表现:规模与成长,2019-2024年
  • 全球人工智慧(AI)控制灌註生物反应器市场预测:规模与成长,2024-2029年,2034年预测
  • 全球人工智慧(AI)控制灌註生物反应器市场:潜在市场规模(TAM)

第六章 市场细分

  • 全球人工智慧(AI)控制灌註生物反应器市场:按产品类型划分,实际结果和预测,2019-2024年、2024-2029年预测、2034年预测
  • 一次性灌註生物反应器
  • 多用途灌註生物反应器
  • 全球人工智慧(AI)控制灌註生物反应器市场:按AI控制类型划分,实际结果和预测,2019-2024年、2024-2029年预测、2034年预测
  • 预测分析
  • 流程优化
  • 即时监控
  • 自动回馈控制
  • 其他人工智慧控制类型
  • 全球人工智慧(AI)控制灌註生物反应器市场:按应用领域划分,实际结果和预测,2019-2024年、2024-2029年预测、2034年预测
  • 细胞疗法
  • 单株抗体生产
  • 疫苗生产
  • 干细胞研究
  • 其他用途
  • 全球人工智慧(AI)控制灌註生物反应器市场:依最终用户划分,实际值和预测值,2019-2024年、2024-2029年预测值、2034年预测值
  • 生物製药公司
  • 学术研究机构
  • 契约製造组织
  • 其他最终用户
  • 全球人工智慧(AI)控制灌註生物反应器市场:按一次性灌註生物反应器类型细分,实际值和预测值,2019-2024年、2024-2029年预测值、2034年预测值
  • 一次性袋式生物反应器
  • 模组化单室生物反应器
  • 无菌单腔生物反应器
  • 全球人工智慧(AI)控制灌註生物反应器市场:多用途灌註生物反应器按类型细分,实际数据及预测(2019-2024年、2024-2029年预测、2034年预测)。
  • 不銹钢生物反应器
  • 玻璃生物反应器
  • 多容器连续培养系统

第七章 区域和国家分析

  • 全球人工智慧(AI)控制灌註生物反应器市场:区域分析、预测与成长,2019-2024年、2024-2029年预测、2034年预测
  • 全球人工智慧(AI)控制灌註生物反应器市场:国家、性能和预测,2019-2024年、2024-2029年预测、2034年预测

第八章 亚太市场

第九章:中国市场

第十章 印度市场

第十一章 日本市场

第十二章:澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章:德国市场

第十八章:法国市场

第十九章:义大利市场

第二十章:西班牙市场

第21章 东欧市场

第22章:俄罗斯市场

第23章 北美市场

第24章美国市场

第25章:加拿大市场

第26章 南美洲市场

第27章:巴西市场

第28章 中东市场

第29章:非洲市场

第三十章:竞争格局与公司概况

  • 人工智慧(AI)控制灌註生物反应器市场:竞争格局
  • 人工智慧(AI)控制灌註生物反应器市场:公司概况
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • Lonza Group AG. Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Sartorius Aktiengesellschaft Overview, Products and Services, Strategy and Financial Analysis

第31章:其他领先和创新企业

  • Getinge AB.
  • WuXi Biologics Inc.
  • Eppendorf Aktiengesellschaft
  • ABEC Inc.
  • Catalyx.ai
  • PBS Biotech Inc.
  • Cytovance Biologics
  • Culture Biosciences Inc.
  • Esco Lifesciences Group Ltd.
  • Cell Culture Company GmbH
  • Synthecon Inc.
  • OmniBRx Biotechnologies Inc.
  • ProlifeCell Inc.
  • Sciperio Ltd.
  • The Cultivated B Ltd.

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章:高潜力市场国家、细分市场与策略

  • 2029年人工智慧(AI)控制灌註生物反应器市场:提供新机会的国家
  • 2029年人工智慧(AI)控制灌註生物反应器市场:提供新机会的细分市场
  • 2029年人工智慧(AI)控制灌註生物反应器市场:成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r39317

A perfusion bioreactor with artificial intelligence control is a bioreactor system designed for continuous cell culture that delivers fresh media and removes waste. Artificial intelligence monitors critical parameters and automatically adjusts conditions to optimize productivity, consistency, and efficiency in the manufacturing of biologics or cell-based products.

The main product types of perfusion bioreactors with artificial intelligence control include single-use perfusion bioreactors and multi-use perfusion bioreactors. Single-use perfusion bioreactors are disposable systems used for continuous cell culture that enhance scalability and minimize contamination risks in biomanufacturing. Artificial intelligence control features include predictive analytics, process optimization, real-time monitoring, automated feedback control, and others. These bioreactors are used in applications such as cell therapy, monoclonal antibody production, vaccine manufacturing, stem cell research, and others, and serve end users including biopharmaceutical companies, academic and research institutes, contract manufacturing organizations, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The perfusion bioreactor with artificial intelligence (AI) control market research report is one of a series of new reports from The Business Research Company that provides perfusion bioreactor with artificial intelligence (AI) control market statistics, including perfusion bioreactor with artificial intelligence (AI) control industry global market size, regional shares, competitors with a perfusion bioreactor with artificial intelligence (AI) control market share, detailed perfusion bioreactor with artificial intelligence (AI) control market segments, market trends and opportunities, and any further data you may need to thrive in the perfusion bioreactor with artificial intelligence (AI) control industry. This perfusion bioreactor with artificial intelligence (AI) control market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The perfusion bioreactor with artificial intelligence (AI) control market size has grown exponentially in recent years. It will grow from $1.55 billion in 2024 to $1.88 billion in 2025 at a compound annual growth rate (CAGR) of 21.3%. The growth during the historic period can be attributed to the rising adoption of single use bioreactors, the increasing investment in biopharmaceutical research and development, the growing demand for efficient cell culture systems, the expanding focus on continuous bioprocessing approaches, and the increasing level of automation in manufacturing processes.

The perfusion bioreactor with artificial intelligence (AI) control market size is expected to see exponential growth in the next few years. It will grow to $4.02 billion in 2029 at a compound annual growth rate (CAGR) of 20.9%. The growth during the forecast period can be attributed to the rising adoption of digital health technologies, the growing preference for hybrid bioreactor solutions, the increasing demand for advanced monitoring systems, the expanding applications in personalized medicine, and the growing government support for bioprocessing innovation. Major trends during the forecast period include technological advancements in artificial intelligence driven control platforms, innovations in continuous bioprocessing methods, developments in automated monitoring and control systems, research and development in precision medicine applications, and the integration with digital manufacturing ecosystems.

The increasing adoption of personalized medicine is expected to drive the growth of the perfusion bioreactor with artificial intelligence control market in the coming years. Personalized medicine is a medical approach that tailors treatment to an individual's genetic, molecular, and clinical characteristics for more accurate and effective care. The demand for personalized medicine is growing due to advances in genomics, which enable therapies customized to a patient's genetic profile for improved efficacy and safety. Perfusion bioreactors with artificial intelligence control support personalized medicine by enabling precise, continuous production of patient-specific cells, such as stem cells or engineered tissues, under tightly regulated conditions. For example, in February 2024, according to the Personalized Medicine Coalition, a United States-based non-profit organization, the FDA approved 16 new personalized treatments for rare disease patients in 2023, an increase from six approvals in 2022. These newly approved therapies included seven cancer drugs and three treatments for other diseases and conditions. Therefore, the growing adoption of personalized medicine is fueling the expansion of the perfusion bioreactor with artificial intelligence control market.

Leading companies in the perfusion bioreactor with artificial intelligence control market are focusing on developing innovative solutions such as artificial intelligence enhanced real-time bioprocess monitoring to optimize cell culture performance, improve product yield, and lower operational costs in biopharmaceutical manufacturing. Artificial intelligence enhanced real-time bioprocess monitoring involves the use of artificial intelligence algorithms to continuously analyze bioreactor data, providing real-time insights, predictive adjustments, and optimization of cell growth and product quality during biomanufacturing. For instance, in February 2025, The Cultivated B GmbH, a Germany-based biotechnology company, introduced artificial intelligence driven multi-channel biosensors to enhance real-time monitoring of bioreactors used in cell culture and fermentation processes. These biosensors provide continuous, high-resolution data analytics, enabling bioprocess engineers to track growth and metabolism with high sensitivity, detecting molecules at sub-picomolar levels such as glucose, amino acids, and lactic acid. The integration of artificial intelligence provides real-time insights and recommendations to optimize media formulation, enhance measurement accuracy, minimize contamination risk by removing manual sampling, and accelerate product development across pharmaceuticals, biologics, food biotechnology, waste upcycling, and alternative protein production.

In August 2025, Culture Biosciences Inc., a United States-based biotechnology company, partnered with Cytiva Bioscience Holding Ltd. to advance digital bioprocessing solutions. The partnership aims to accelerate and reduce risks in upstream bioprocess development by offering scalable, cloud-connected, and digitally integrated bioreactor systems that enable faster and more reliable therapeutic production from laboratory to commercial scale. Cytiva Bioscience Holding Ltd. is a United States-based biotechnology company that provides perfusion bioreactors with artificial intelligence control.

Major players in the perfusion bioreactor with artificial intelligence (ai) control market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG., Danaher Corporation, Sartorius Aktiengesellschaft, Getinge AB., WuXi Biologics Inc., Eppendorf Aktiengesellschaft, ABEC Inc., Catalyx.ai, PBS Biotech Inc., Cytovance Biologics, Culture Biosciences Inc., Esco Lifesciences Group Ltd., Cell Culture Company GmbH, Synthecon Inc., OmniBRx Biotechnologies Inc., ProlifeCell Inc., Sciperio Ltd., and The Cultivated B Ltd.

North America was the largest region in the perfusion bioreactor with artificial intelligence (AI) control market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in perfusion bioreactor with artificial intelligence (AI) control report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the perfusion bioreactor with artificial intelligence (AI) control market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The perfusion bioreactor with artificial intelligence (AI) control market consists of revenues earned by entities by providing services such as cell culture management, nutrient and waste regulation, AI-driven process control, performance optimization, and automated data analytics. The market value includes the value of related goods sold by the service provider or included within the service offering. The perfusion bioreactor with artificial intelligence (AI) control market includes sales of automated perfusion bioreactor systems, hybrid perfusion bioreactors, and AI-integrated bench-scale perfusion bioreactors. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Perfusion Bioreactor With Artificial Intelligence (AI) Control Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on perfusion bioreactor with artificial intelligence (ai) control market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for perfusion bioreactor with artificial intelligence (ai) control ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The perfusion bioreactor with artificial intelligence (ai) control market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Single Use Perfusion Bioreactors; Multi-Use Perfusion Bioreactors
  • 2) By Artificial Intelligence (AI) Control Type: Predictive Analytics; Process Optimization; Real-Time Monitoring; Automated Feedback Control; Other Artificial Intelligence (AI) Control Types
  • 3) By Application: Cell Therapy; Monoclonal Antibody Production; Vaccine Manufacturing; Stem Cell Research; Other Applications
  • 4) By End-User: Biopharmaceutical Companies; Academic And Research Institutes; Contract Manufacturing Organizations; Other End-Users
  • Subsegments:
  • 1) By Single-Use Perfusion Bioreactors: Disposable Bag Bioreactors; Modular Single-Chamber Bioreactors; Pre-Sterilized Single-Vessel Bioreactors
  • 2) By Multi-Use Perfusion Bioreactors: Stainless Steel Bioreactors; Glass Bioreactors; Multi-Vessel Continuous Culture Systems
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Merck KGaA; Lonza Group AG.; Danaher Corporation; Sartorius Aktiengesellschaft; Getinge AB.; WuXi Biologics Inc.; Eppendorf Aktiengesellschaft; ABEC Inc.; Catalyx.ai; PBS Biotech Inc.; Cytovance Biologics; Culture Biosciences Inc.; Esco Lifesciences Group Ltd.; Cell Culture Company GmbH; Synthecon Inc.; OmniBRx Biotechnologies Inc.; ProlifeCell Inc.; Sciperio Ltd.; The Cultivated B Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Characteristics

3. Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Trends And Strategies

4. Perfusion Bioreactor With Artificial Intelligence (AI) Control Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Perfusion Bioreactor With Artificial Intelligence (AI) Control Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Perfusion Bioreactor With Artificial Intelligence (AI) Control PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Growth Rate Analysis
  • 5.4. Global Perfusion Bioreactor With Artificial Intelligence (AI) Control Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Perfusion Bioreactor With Artificial Intelligence (AI) Control Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Perfusion Bioreactor With Artificial Intelligence (AI) Control Total Addressable Market (TAM)

6. Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Segmentation

  • 6.1. Global Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Use Perfusion Bioreactors
  • Multi-Use Perfusion Bioreactors
  • 6.2. Global Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Predictive Analytics
  • Process Optimization
  • Real-Time Monitoring
  • Automated Feedback Control
  • Other Artificial Intelligence (AI) Control Types
  • 6.3. Global Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cell Therapy
  • Monoclonal Antibody Production
  • Vaccine Manufacturing
  • Stem Cell Research
  • Other Applications
  • 6.4. Global Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biopharmaceutical Companies
  • Academic And Research Institutes
  • Contract Manufacturing Organizations
  • Other End-Users
  • 6.5. Global Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Sub-Segmentation Of Single-Use Perfusion Bioreactors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Disposable Bag Bioreactors
  • Modular Single-Chamber Bioreactors
  • Pre-Sterilized Single-Vessel Bioreactors
  • 6.6. Global Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Sub-Segmentation Of Multi-Use Perfusion Bioreactors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Stainless Steel Bioreactors
  • Glass Bioreactors
  • Multi-Vessel Continuous Culture Systems

7. Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Regional And Country Analysis

  • 7.1. Global Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 8.1. Asia-Pacific Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 9.1. China Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Overview
  • 9.2. China Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 10.1. India Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 11.1. Japan Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Overview
  • 11.2. Japan Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 12.1. Australia Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 13.1. Indonesia Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 14.1. South Korea Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Overview
  • 14.2. South Korea Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 15.1. Western Europe Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Overview
  • 15.2. Western Europe Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 16.1. UK Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 17.1. Germany Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 18.1. France Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 19.1. Italy Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 20.1. Spain Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 21.1. Eastern Europe Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Overview
  • 21.2. Eastern Europe Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 22.1. Russia Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 23.1. North America Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Overview
  • 23.2. North America Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 24.1. USA Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Overview
  • 24.2. USA Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 25.1. Canada Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Overview
  • 25.2. Canada Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 26.1. South America Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Overview
  • 26.2. South America Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 27.1. Brazil Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 28.1. Middle East Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Overview
  • 28.2. Middle East Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

  • 29.1. Africa Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Overview
  • 29.2. Africa Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Artificial Intelligence (AI) Control Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Perfusion Bioreactor With Artificial Intelligence (AI) Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Competitive Landscape And Company Profiles

  • 30.1. Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Competitive Landscape
  • 30.2. Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Lonza Group AG. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Sartorius Aktiengesellschaft Overview, Products and Services, Strategy and Financial Analysis

31. Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Other Major And Innovative Companies

  • 31.1. Getinge AB.
  • 31.2. WuXi Biologics Inc.
  • 31.3. Eppendorf Aktiengesellschaft
  • 31.4. ABEC Inc.
  • 31.5. Catalyx.ai
  • 31.6. PBS Biotech Inc.
  • 31.7. Cytovance Biologics
  • 31.8. Culture Biosciences Inc.
  • 31.9. Esco Lifesciences Group Ltd.
  • 31.10. Cell Culture Company GmbH
  • 31.11. Synthecon Inc.
  • 31.12. OmniBRx Biotechnologies Inc.
  • 31.13. ProlifeCell Inc.
  • 31.14. Sciperio Ltd.
  • 31.15. The Cultivated B Ltd.

32. Global Perfusion Bioreactor With Artificial Intelligence (AI) Control Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

34. Recent Developments In The Perfusion Bioreactor With Artificial Intelligence (AI) Control Market

35. Perfusion Bioreactor With Artificial Intelligence (AI) Control Market High Potential Countries, Segments and Strategies

  • 35.1 Perfusion Bioreactor With Artificial Intelligence (AI) Control Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Perfusion Bioreactor With Artificial Intelligence (AI) Control Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Perfusion Bioreactor With Artificial Intelligence (AI) Control Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer